கண் குரா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Israel s proptech sector, broken down
calcalistech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calcalistech.com Daily Mail and Mail on Sunday newspapers.
iAngels Raises $55 5 Million for First Institutional Fund Supported by EIF
crowdfundinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crowdfundinsider.com Daily Mail and Mail on Sunday newspapers.
iAngels Ventures Raises $55 5M (€47M) for First Institutional Fund Anchored by the European Investment Fund Bringing Total AUM to over $300M (€255M)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
April 1, 2021
By Bio-IT World Staff
April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.
$969M Investment Fund for Early to Late-Stage Companies
Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market. Foresite Capital now has ~$4 billion in assets under management. Press release.
Israeli AI surgical intelligence co Theator raises $15.5m
Theator s AI-powered platform is based on smart annotation and cutting edge.
Israeli AI surgical intelligence platform company Theator today announced that it has completed a $15.5 million oversubscribed Series A financing round led by Insight Partners, with new investor Blumberg Capital, and existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Notable individual investors including 23andMe s cofounder and CEO Anne Wojcicki, former Netflix CPO Neil Hunt, and Zebra Medical Vision s cofounder Eyal Gura also participated in the round.
The round will be used by Theator to expand commercial operations and partnerships with US providers, enlarge its R&D team and consolidate its status as a leading provider of AI-powered surgical intelligence solutions to improve the performance of surgeons. Theator has raised $18.5 million to date.